Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | RGX-019 |
Synonyms | |
Therapy Description |
RGX-019 is a monoclonal antibody that selectively targets Mertk for internalization and degradation, leading to inhibition of cancer cell growth (AACR Annual Meeting 2019, Abstract LB-277). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RGX-019 | RGX019|RGX 019 | MERTK Antibody 1 | RGX-019 is a monoclonal antibody that selectively targets Mertk for internalization and degradation, leading to inhibition of cancer cell growth (AACR Annual Meeting 2019, Abstract LB-277). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|